1. McNeill, Rhiannon V, Palladino, Viola Stella, Brunkhorst-Kanaan, Nathalie, Reif, Andreas, Kittel-Schneider, Sarah. 2020. Expression of the adult ADHD-associated gene ADGRL3 is dysregulated by risk variants and environmental risk factors. In The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 22, 335-349. doi:10.1080/15622975.2020.1809014. https://pubmed.ncbi.nlm.nih.gov/32787626/
2. Bruxel, E M, Moreira-Maia, C R, Akutagava-Martins, G C, Rohde, L A, Hutz, M H. 2020. Meta-analysis and systematic review of ADGRL3 (LPHN3) polymorphisms in ADHD susceptibility. In Molecular psychiatry, 26, 2277-2285. doi:10.1038/s41380-020-0673-0. https://pubmed.ncbi.nlm.nih.gov/32051549/
3. Vidal, Oscar M, Vélez, Jorge I, Arcos-Burgos, Mauricio. 2022. ADGRL3 genomic variation implicated in neurogenesis and ADHD links functional effects to the incretin polypeptide GIP. In Scientific reports, 12, 15922. doi:10.1038/s41598-022-20343-z. https://pubmed.ncbi.nlm.nih.gov/36151371/
4. McNeill, Rhiannon V, Radtke, Franziska, Nieberler, Matthias, Chiocchetti, Andreas G, Kittel-Schneider, Sarah. 2023. Generation of four human induced pluripotent stem cells derived from ADHD patients carrying different genotypes for the risk SNP rs1397547 in the ADHD-associated gene ADGRL3. In Stem cell research, 67, 103016. doi:10.1016/j.scr.2023.103016. https://pubmed.ncbi.nlm.nih.gov/36640473/
5. Arcos-Burgos, Mauricio, Vélez, Jorge I, Martinez, Ariel F, Mastronardi, Claudio A, Muenke, Maximilian. 2019. ADGRL3 (LPHN3) variants predict substance use disorder. In Translational psychiatry, 9, 42. doi:10.1038/s41398-019-0396-7. https://pubmed.ncbi.nlm.nih.gov/30696812/
智鼠故事 
